Emerging Therapies for Ulcerative Colitis: Updates from Recent Clinical Trials.

ABSTRACT: Ulcerative colitis (UC) is a chronic and progressive inflammatory disorder that affects the colon. The advent of advanced therapies such as biologic agents and small molecules has revolutionized the management of UC. Despite the expanding therapeutic armamentarium of advanced therapies to treat UC, the overall net remission rates and durability of currently available agents are relatively low. This highlights the need for further drug development and more innovative clinical trial design. There are currently multiple emerging agents in the pipeline for the management of UC. This includes agents with alternative routes of administration such as oral or subcutaneous tumor necrosis factor inhibitors or novel mechanisms of action such as toll-like receptor 9 (TLR9) agonist cobitolimod and phos

SUBMITTER: AlAmeel T 

PROVIDER: S-EPMC10441644 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature